BridgeBio Pharma (BBIO) Change in Inventory (2025 - 2026)
BridgeBio Pharma recorded quarterly Change in Inventory of $7.1 million in Q1 2026, up 261.51% quarter-over-quarter from $2.0 million in Q4 2025, and up 120.89% year-over-year from $3.2 million in Q1 2025.
BridgeBio Pharma's Change in Inventory history runs 2 years deep, the most recent figure standing at $7.1 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 120.89% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $29.2 million (up 813.47% YoY), while the FY2025 annual figure was $25.3 million, changed N/A from the prior year.
- Change in Inventory came in at $7.1 million for Q1 2026 at BridgeBio Pharma, up from $2.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $13.4 million in Q2 2025 to a low of $2.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.32 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.05 Mn |
| Mar 31, 2026 | 7.05 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Jun 30, 2025 | 13.39 Mn |
| Jun 30, 2025 | 13.39 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Mar 31, 2025 | 3.19 Mn |